Preparation and Characterization of a Dry Powder Inhaler Composed of PLGA Large Porous Particles Encapsulating Gentamicin Sulfate

Advanced Pharmaceutical Bulletin
Farideh ShiehzadehMohsen Imenshahidi

Abstract

Purpose: Direct delivery of aminoglycosides to the lungs was under extensive evaluations during the last decades. Because of large particle size, low density and porous structure, large porous particles (LPPs) are versatile carriers for this purpose. In this study, poly (lactic-co-glycolic acid) (PLGA) LPPs encapsulating gentamicin sulfate were prepared and in vitro characteristics of their freeze-dried powder as a dry powder inhaler (DPI) were evaluated. Methods: To prepare PLGA LPPs, a double emulsification-solvent evaporation method was optimized and gentamicin sulfate was post-loaded in the LPPs. in vitro characteristics including morphological features, thermal behavior, aerodynamic profile and cumulative drug release were evaluated by the scanning electron microscope (SEM), differential scanning calorimetry (DSC), next-generation cascade impactor (NGI) and Franz diffusion cell respectively. Results: The obtained results revealed that the preparation method was capable to produce spherical large homogenous highly porous particles. 94% of gentamicin sulfate released from LPPs up to 30 minutes. Mass median aerodynamic diameter (MMAD) and fine particle fraction (FPF) were 4.9 µm and 39% respectively. Conclusion: In thi...Continue Reading

References

Jun 20, 1997·Science·D A EdwardsR Langer
Mar 9, 2000·Journal of Pharmaceutical and Biomedical Analysis·P FrutosG Frutos
Apr 9, 2002·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Abdulsalam I Al-AmoudHenry Chrystyn
May 26, 2004·International Journal of Pharmaceutics·Hartwig Steckel, Heike G Brandes
Feb 14, 2006·International Journal of Antimicrobial Agents·Gavin RukholmAbdelwahab Omri
Mar 1, 2006·International Journal of Pharmaceutics·D KloseJ Siepmann
Jun 30, 2006·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Francesca UngaroMaria Immacolata La Rotonda
May 23, 2007·Antimicrobial Agents and Chemotherapy·L Garcia-ContrerasD Edwards
May 13, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Amit RawatFakhrul Ahsan
Sep 25, 2008·International Journal of Pharmaceutics·Christian WischkeDirk R Lorenzen
Oct 8, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Soon Eon BaeDong Keun Han
Aug 25, 2010·Colloids and Surfaces. B, Biointerfaces·Shohreh AlipourMohsen Tafaghodi
Mar 29, 2014·Annals of the American Thoracic Society·Bradley S QuonBonnie W Ramsey
Jun 3, 2016·Cold Spring Harbor Perspectives in Medicine·Kevin M KrauseLynn E Connolly
Mar 23, 2017·Drug Development and Industrial Pharmacy·Zahra BakhtiaryYadollah Omidi
Jul 19, 2018·Expert Opinion on Drug Delivery·Nashwa OsmanImran Saleem
Aug 25, 2018·Pharmaceutical Research·Erin M WilsonJoseph M DeSimone

❮ Previous
Next ❯

Citations

Oct 16, 2020·Progress in Biomaterials·Elena LagrecaRaffaele Vecchione
Apr 5, 2021·International Journal of Pharmaceutics·Shadi YaqoubiHamed Hamishehkar

❮ Previous
Next ❯

Methods Mentioned

BETA
scanning electron microscopy
differential scanning calorimetry

Software Mentioned

GraphPad InStat

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.